By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
Health Works CollectiveHealth Works CollectiveHealth Works Collective
  • Health
    • Mental Health
    Health
    Healthcare organizations are operating on slimmer profit margins than ever. One report in August showed that they are even lower than the beginning of the…
    Show More
    Top News
    UV damage to eyes
    Warning Signs of Long-Term UV Damage to Your Eyes
    December 9, 2021
    degree for healthcare job
    The Ultimate Healthcare Recruiting and Staffing Guidebook
    March 21, 2022
    medicare part d benefits
    Everything that You Need to Know About Medicare Part D
    August 15, 2022
    Latest News
    Beyond Nutrition: Everyday Foods That Support Whole-Body Health
    June 15, 2025
    The Wide-Ranging Benefits of Magnesium Supplements
    June 11, 2025
    The Best Home Remedies for Migraines
    June 5, 2025
    The Hidden Impact Of Stress On Your Body’s Alignment And Balance
    May 22, 2025
  • Policy and Law
    • Global Healthcare
    • Medical Ethics
    Policy and Law
    Get the latest updates about Insurance policies and Laws in the Healthcare industry for different geographical locations.
    Show More
    Top News
    nursing program
    7 Tips to Picking the Best Nursing Program
    February 5, 2018
    Health Care: A Modern-Day Blade Runner?
    December 10, 2014
    Occupational Therapy Assistant | Medical Assistant | Home Health Aide
    In-Demand Healthcare Support Jobs
    April 16, 2016
    Latest News
    Top HIPAA-Compliant Messaging Apps for Healthcare Teams
    June 25, 2025
    When Healthcare Ends, the Legal Process Begins: What Families Should Know About Probate and Medical Estates
    June 20, 2025
    Preventing Contamination In Healthcare Facilities Starts With Hygiene
    June 15, 2025
    Strengthening Healthcare Systems Through Clinical and Administrative Career Development
    June 13, 2025
  • Medical Innovations
  • News
  • Wellness
  • Tech
Search
© 2023 HealthWorks Collective. All Rights Reserved.
Reading: Lessons on Transparency, “Sexy Science” and Compelling Business Cases
Share
Notification Show More
Font ResizerAa
Health Works CollectiveHealth Works Collective
Font ResizerAa
Search
Follow US
  • About
  • Contact
  • Privacy
© 2023 HealthWorks Collective. All Rights Reserved.
Health Works Collective > Business > Finance > Lessons on Transparency, “Sexy Science” and Compelling Business Cases
BusinessFinanceTechnology

Lessons on Transparency, “Sexy Science” and Compelling Business Cases

Deanna Pogorelc
Last updated: December 27, 2013 9:00 am
Deanna Pogorelc
Share
5 Min Read
SHARE

carol gallagher frazier healthcareFirst published on MedCityNews.com. Frazier Healthcare’s newest venture partner is approaching her new gig with the smarts of a scientist, the gusto of an entrepreneur and the wisdom of a CEO who’s both exited and shut down a company.

carol gallagher frazier healthcareFirst published on MedCityNews.com. Frazier Healthcare’s newest venture partner is approaching her new gig with the smarts of a scientist, the gusto of an entrepreneur and the wisdom of a CEO who’s both exited and shut down a company.

Carol Gallagher joined the firm’s Menlo Park office this fall and told me it was a great opportunity to combine several of her passions and skills, and to help entrepreneurs build companies with the potential to bring new options to patients.

Gallagher most recently held the reins at Calistoga Pharmaceuticals, a cancer drug development company (backed by Frazier as well as Alta Partners, Amgen Ventures and a handful of other VCs) that sold to Gilead in 2011 for $375 million. That certainly doesn’t look bad on her resume, but she also credits another, much less fortunate experience with helping boost her credibility with the Frazier team.

More Read

Healthcare IT VC Funding Almost Doubled in 2013
A Look Into Designing The Smart Hospitals Of Tomorrow
Latest Medical Technology Is Cool, But Will It Ever Be Used?
10 Essential Qualities Of A Virtual Medical Assistant
Forrester Predictions for Healthcare CIOs in 2016

She worked with members of the firm back in the mid-2000s while leading a small molecule drug development company called Metastatix. Eventually, she realized the company didn’t have what it thought it had and made the tough decision to recommend to the board that the company shut down.

“It was a good stepping stone in my career, because I was then recognized as somebody who did understand what needed to go into the package, in terms of what we needed to demonstrate a sufficient hypothesis for investment,” she said. “When the data just wasn’t there to further support the hypothesis, it was the very right thing to do in terms of protecting the investors’ capital.”

That understanding of “what needs to go into the package” comes from two decades in the pharmaceutical industry at companies like Eli Lilly, Amgen, Pfizer and Biogen Idec. A pharmacist by training, Gallagher said that as an investor, she’s intrigued by company founders and CEOs who have a passion for the science behind their product. But she’s also learned that good science doesn’t always constitute a good investment opportunity.

“People sometimes fall in love with sexy science without thinking what the business opportunity should be, or they sometimes get focused on having a clear regulatory path without ensuring that path enables commercial differentiation and adoption,” she explained.  “Have you compelled the community that now you have a better choice for a select group of patients?  If not, then you won’t get adoption.”

Gallagher said she’ll definitely focus on oncology in her role at Frazier; it’s a good fit given her experience, the unmet needs that still exist and the way that cancer drug development tends to work well with the venture capital model. But expect to see her taking a close look at some other markets, too — potentially antibiotics, ophthalmology, dermatology and therapies for autoimmune diseases and CNS disorders.

“(Having a compelling business case) doesn’t mean it has to be a big market, it means there has to be unmet medical need that can be met,” she explained. “It’s not necessarily about how many thousands of patients are affected by that disease but to what extent can you address that disease with a better therapeutic approach.”

She’s entering the VC world at an interesting time, as the life sciences industry has seen downward-trending dealflow over the past few years (and a few firms even walking away from the sector), yet biotech IPOs seemed to have re-entered the picture.

Gallagher remains bullish on biotech investing and noted that it’s probably good for the industry to have a more focused group of venture investors now. And with public investors back at the table, entrepreneurs have more options to access capital.

“This really does take a village,” she said. “This is such a team sport, so I just can’t say enough about how important it is within a company to build a great team — and investors are part of that, too.”

[Image credit: Frazier Healthcare]

Share This Article
Facebook Copy Link Print
Share

Stay Connected

1.5kFollowersLike
4.5kFollowersFollow
2.8kFollowersPin
136kSubscribersSubscribe

Latest News

women dental care
What Is a Smile Makeover and How Much Does It Cost?
Dental health
June 30, 2025
HIPAA-Compliant Messaging Apps
Top HIPAA-Compliant Messaging Apps for Healthcare Teams
Global Healthcare Policy & Law Technology
June 25, 2025
recovering from injury
Rebuilding After Injury: Path to Physical and Emotional Recovery
News
June 22, 2025
scientist using microscope
When Healthcare Ends, the Legal Process Begins: What Families Should Know About Probate and Medical Estates
Global Healthcare
June 18, 2025

You Might also Like

Walmart. Save Money. Live Better.
BusinessNews

Walmart Moves Health Care Forward Again

October 13, 2012
SEO versus PPC, Online Medical Marketing
BusinessFinance

The Effectiveness of SEO vs. PPC in Physician Marketing Plans

October 24, 2014
eHealthHealth careTechnology

The Future of Healthcare and Big Pharma is in Big Data Analytics

July 25, 2017
Hospital Marketing, Healthcare Marketing, Healthcare Marketing for Men
Business

Hospital Marketing for the Most Reluctant Patients: Men

August 7, 2014
Subscribe
Subscribe to our newsletter to get our newest articles instantly!
Follow US
© 2008-2025 HealthWorks Collective. All Rights Reserved.
  • About
  • Contact
  • Privacy
Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?